Nanotechnology-Based Therapies for Preventing Post-Surgical Adhesions DOI Creative Commons

Zi Yi Teo,

Samyuktha Dhanalakshmi Senthilkumar,

Dinesh Kumar Srinivasan

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 389 - 389

Опубликована: Март 19, 2025

Adhesions are the body’s natural response to various inflammatory causes, with surgery being most common cause. However, formation of postoperative adhesions can lead significant complications, including intestinal obstruction and chronic pain. To prevent such complications associated adhesions, developing effective strategies for adhesion prevention has been a major focus research. Currently, several therapeutic models have developed achieve this objective. These include pharmaceuticals, inert polymers, functional biomaterials, nanotherapeutics. Among developed, nanotherapeutics, though still in its early stages, shown promise as potential approach. Other adverse side effects related their application. On other hand, nanotherapeutic able overcome limitations provide own set unique advantages. Hence, nanotherapeutics represents promising area further Further efforts should be made refine existing clinical application while also addressing safety ethical concerns use medical practice. Therefore, article aims review approaches explore regulatory pathways, discuss concerns.

Язык: Английский

Nanotechnology-Based Therapies for Preventing Post-Surgical Adhesions DOI Creative Commons

Zi Yi Teo,

Samyuktha Dhanalakshmi Senthilkumar,

Dinesh Kumar Srinivasan

и другие.

Pharmaceutics, Год журнала: 2025, Номер 17(3), С. 389 - 389

Опубликована: Март 19, 2025

Adhesions are the body’s natural response to various inflammatory causes, with surgery being most common cause. However, formation of postoperative adhesions can lead significant complications, including intestinal obstruction and chronic pain. To prevent such complications associated adhesions, developing effective strategies for adhesion prevention has been a major focus research. Currently, several therapeutic models have developed achieve this objective. These include pharmaceuticals, inert polymers, functional biomaterials, nanotherapeutics. Among developed, nanotherapeutics, though still in its early stages, shown promise as potential approach. Other adverse side effects related their application. On other hand, nanotherapeutic able overcome limitations provide own set unique advantages. Hence, nanotherapeutics represents promising area further Further efforts should be made refine existing clinical application while also addressing safety ethical concerns use medical practice. Therefore, article aims review approaches explore regulatory pathways, discuss concerns.

Язык: Английский

Процитировано

0